The life sciences sector has experienced a challenging 2025, marked by federal policy shifts under the Trump administration, including proposed cuts to National Institutes of Health funding, withdrawal of government backing for mRNA vaccine initiatives, new tariffs, and drug pricing reforms. Philadelphia’s biotech ecosystem has felt the impact. Nearly 1,000 local life sciences jobs have… Read more »